The Binding Site Group Ltd.

Biopharma Acquisitions Biopharma merger and acquisition value for the fourth quarter of 2022 reached $35.7bn from 41 transactions, 21 of which had disclosed values. Making up 78% of the Q4 total was A

Thermo Fisher Scientific has agreed to purchase The Binding Site , a manufacturer of precision diagnostics for melanoma, blood cancer and immune system disorder applications from its current owner,

There were two $1bn+ deals signed in October. Topping the list was a potential $1.76bn deal between Jazz Pharmaceuticals plc and Zymeworks, Inc. in which Jazz acquires development and commercializ

[ Editor's Note: A version of this article originally appeared in In Vivo .] The annual MedTech Forum was back to its “in-person” best in May 2022, having adjusted to the pandemic needs over the p